Nalaganje...

Pharmacokinetics of cefotaxime and desacetylcefotaxime in patients with liver disease.

The dispositions of cefotaxime and its metabolite desacetylcefotaxime were investigated in patients with different forms of chronic parenchymal liver disease (CPLD). A total of 31 subjects (27 patients and 4 controls) received a single 2-g dose of cefotaxime by infusion, and serial blood samples wer...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antimicrob Agents Chemother
Main Authors: Ko, R J, Sattler, F R, Nichols, S, Akriviadis, E, Runyon, B, Appleman, M, Cohen, J L, Koda, R T
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 1991
Teme:
Online dostop:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245175/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1929296/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.7.1376
Oznake: Označite
Brez oznak, prvi označite!